Sophie Baratte
Chief Executive Officer at CELLNOVO
Sophie Baratte active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CELLNOVO | Director/Board Member | 2016-05-19 | - |
| Chief Executive Officer | 2016-01-29 | - | |
| Investor Relations Contact | 2013-12-31 | - | |
| Chairman | 2016-04-10 | 2016-06-08 | |
| Corporate Officer/Principal | 2013-12-31 | - |
Career history of Sophie Baratte
Former positions of Sophie Baratte
| Companies | Position | Start | End |
|---|---|---|---|
| STENTYS | Director/Board Member | 2017-03-20 | 2021-02-28 |
| Independent Dir/Board Member | 2017-03-20 | 2021-02-28 | |
Cellnovo Ltd.
 Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Training of Sophie Baratte
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| University of Compiègne | Doctorate Degree |
Statistics
International
| France | 5 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Chairman | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Health Technology |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Sophie Baratte
- Experience
